Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema

      Background

      The objective of lung transplantation (LTx) is to prolong life, but the survival benefit for patients with severe α1-anti-trypsin deficiency (PiZZ) and emphysema is still unclear. The aim of this study was to assess whether PiZZ patients who have undergone lung transplantation (the lung transplant group, TxG) do better than patients who have continued on the usual medical therapy (the non-transplant group, NTxG).

      Methods

      Between 1990, when the first patient received a lung transplant in Sweden, until June 2010, a total of 83 PiZZ patients with severe emphysema underwent transplantation. Seventy appropriate controls were identified from the Swedish National AAT Deficiency Registry. Each control was matched with a patient who had received a lung transplant, for age, gender, smoking history (number of pack-years) and lung function at the time of transplantation.

      Results

      Both controls and lung transplant patients had low spirometric values with a mean FEV1 of 23 ± 6% and 22 ± 9% of predicted value, respectively (not a statistically significant difference). Of the 83 transplant patients, 62 (75%) underwent single-lung transplantation (SLTx). During follow-up, 37 (45%) deaths occurred in the TxG and 45 (64%) in the NTxG. In the TxG, the estimated median survival time was 11 years (95% confidence interval [CI] 9 to 14 years), compared with 5 years (95% CI 4 to 6 years) for the NTxG (p = 0.006). The most common cause of death was pulmonary infection among the transplant patients (38%) and respiratory failure (60%) among the controls.

      Conclusion

      Lung transplantation significantly improves long-term survival of patients with severe α1-anti-trypsin deficiency (PiZZ) and emphysema.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.
        Am J Respir Crit Care Med. 2003; 168: 818-900
        • Tanash H.A.
        • Nilsson P.M.
        • Nilsson J.A.
        • et al.
        Survival in severe alpha-1-antitrypsin deficiency (PiZZ).
        Respir Res. 2010; 11: 44
        • Christie J.D.
        • Edwards L.B.
        • Kucheryavaya A.Y.
        • et al.
        The registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart–lung transplant report—2010.
        J Heart Lung Transplant. 2010; 29: 1104-1118
        • International guidelines for the selection of lung transplant candidates
        The American Society for Transplant Physicians [ASTP]/American Thoracic Society [ATS]/European Respiratory Society [ERS]/International Society for Heart and Lung Transplantation [ISHLT].
        Am J Respir Crit Care Med. 1998; 158: 335-339
        • Celli B.R.
        • Cote C.G.
        • Marin J.M.
        • et al.
        The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
        N Engl J Med. 2004; 350: 1005-1012
        • Orens J.B.
        • Estenne M.
        • Arcasoy S.
        • et al.
        International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.
        J Heart Lung Transplant. 2006; 25: 745-755
        • Charman S.C.
        • Sharples L.D.
        • McNeil K.D.
        • et al.
        Assessment of survival benefit after lung transplantation by patient diagnosis.
        J Heart Lung Transplant. 2002; 21: 226-232
        • De Meester J.
        • Smits J.M.
        • Persijn G.G.
        • et al.
        Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience.
        J Heart Lung Transplant. 2001; 20: 518-524
        • Thabut G.
        • Ravaud P.
        • Christie J.D.
        Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2008; 177: 1056-1063
        • Stavem K.
        • Bjortuft O.
        • Borgan O.
        • et al.
        Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit.
        J Heart Lung Transplant. 2006; 25: 75-84
        • Hosenpud J.D.
        • Bennett L.E.
        • Keck B.M.
        • et al.
        Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.
        Lancet. 1998; 351: 24-27
        • Piitulainen E.
        • Tornling G.
        • Eriksson S.
        Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).
        Thorax. 1997; 52: 244-248
        • Riise G.C.
        • Nilsson F.N.
        • Hansson L.E.
        Lung transplantation in Sweden—more than 500 patients have been operated [in Swedish].
        Lakartidningen. 2009; 106: 1887-1890
        • Cassivi S.D.
        • Meyers B.F.
        • Battafarano R.J.
        • et al.
        Thirteen-year experience in lung transplantation for emphysema.
        Ann Thorac Surg. 2002; 74: 1663-1669
        • Thabut G.
        • Christie J.D.
        • Ravaud P.
        • et al.
        Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data.
        Lancet. 2008; 371: 744-751
        • Meyer K.C.
        • Nunley D.R.
        • Dauber J.H.
        • et al.
        Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation.
        Am J Respir Crit Care Med. 2001; 164: 97-102
        • Eriksson S.
        Alpha-1 antitrypsin deficiency: natural course and therapeutic strategies.
        in: Boyer J. Blum H.E. Maier K.P. Cirrhosis and its development Falk Symposium 115. Kluwer, Dordrecht2000: 305-313